Over-secretion of GDF15 induced by eribulin in our studies of breast cancer cell lines led us to investigate its potential as a pharmacodynamic (PD) response biomarker for eribulin, in addition to its potential utility as a specific biomarker for DTP cell generation. This evidence concerns the gene GDF15 and breast cancer.